New to this website?
Register to gain access to this site by completing a simple form.
Register to gain access to this site by completing a simple form.
For any inquiries relating to the HIV Academy Web-Portal email: info@HIV-Academy.com
For any medical queries relating to Gilead products email: askgileadMe@gilead.com
Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals and patients are asked to report any suspected adverse reactions via the national reporting schemes as applicable in your country. Adverse reactions may also be reported directly to the manufacturer of the suspected product. Adverse reactions related to Gilead products may be reported directly to Gilead via Drugsafety.firstname.lastname@example.org
If you would like to opt out of all communications and cancel your access to the HIV Academy Web-Portal, please contact info@HIV-Academy.com
In the regular course of business, Gilead Sciences, Inc., including its wholly owned subsidiaries and successors (together referred to as “Gilead”) interacts and communicates directly with health care professionals, customers, clinical trial participants, consumers, business partners, regulatory authorities, and others. Through these interactions and communications, personal information may be provided to Gilead and processed electronically and/or manually. Gilead respects individual privacy and values the confidence of such individuals. This Privacy Statement sets forth Gilead's privacy principles with respect to Personal Information, including the privacy procedures and technical security measures Gilead follows in its normal course of business to keep Personal Information private and secure.
Gilead participates in both the EU – U.S. Privacy Shield and U.S. – Swiss Privacy Shield Frameworks. Gilead acknowledges its commitment to comply with the EU – U.S. Privacy Shield and U.S. – Swiss Privacy Shield Principles (“Principles”) for all Personal Information received from the EU or Switzerland which was provided in reliance on Privacy Shield. Gilead will collect, use and disclose Personal Information received from the EU or Switzerland only in accordance with the principles outlined in this Privacy Statement, the above-noted Privacy Shield Principles, and legal requirements. For purposes of Privacy Shield compliance enforcement, Gilead acknowledges that it is subject to the investigatory and enforcement powers of the United States Federal Trade Commission (FTC).
This Privacy Statement applies to Personal Information received by Gilead (including Personal Information received by third-party organizations or individuals acting as Agents of Gilead) from health care professionals, customers, clinical trial participants, consumers, business partners, and other individuals, in any format, including electronic and paper, as part of Gilead's business operations. Types of third-party organizations include Gilead subsidiaries and business partners, a current list of which is available upon request.
Gilead Privacy Statement
The collection, processing, storage, use, and disclosure of Personal Information in the business context is essential to the conduct of many of Gilead’s business functions. Gilead may collect, process, store, use, and disclose Personal Information from individuals directly and/or from third parties, subject to applicable law.PURPOSE FOR COLLECTION, USE AND DISCLOSURE OF PERSONAL INFORMATION
Gilead processes Personal Information where you consent to us doing so. However, there are a number of instances where Gilead does not require your consent to engage in the processing or disclosure of Personal Information. Gilead may not solicit your consent for the processing or transfer of Personal Information for those purposes which have a statutory basis, such as:
Gilead collects, uses and discloses your Personal Information in its normal course of business for the following purposes: Establishing and maintaining communications with you;
WHAT DATA WE COLLECT
When interacting with Gilead, you may choose to provide us with information to help us serve your needs. The Personal Information that we collect will depend on how you choose to interact with Gilead.
Where you participate in Clinical Trials
If you participate in a clinical trial with Gilead, or one of our partners, we will collect Personal Information about you as is necessary to fulfill the purpose of the clinical trial. This can include SPI such as biological and medical information about you. However, as required by the Principles, Personal Information will be Pseudonymized, as appropriate, to both protect your privacy as well as maintain the integrity of the clinical trial.
Where you request information about our services
If you request further information about our services, we require you to submit your name, e-mail address, the name of your organization, and the country in which you are based so we may send you the material you have requested, and to enable us to identify whether you have an existing relationship with Gilead.
Where you register with us and/or request services
If you register with us, or request a service available on the Site, we may ask you for your name, e-mail address, country, telephone number and the reason for your communication; as well as information about your position, organization, and such other information as is reasonably necessary so that we can provide you with the service. On the data submission form, we shall indicate by way of an asterisk, which information is optional and which information is mandatory. This information can include information you provide on applications or other forms, which may include your name, address, email address, and payment information.
Individuals should not provide Gilead with any Personal Information that is not specifically requested. Where Gilead receives Personal Information from its subsidiaries, affiliates, or other entities, it will use or disclose such Personal Information in accordance with the above procedures.
Gilead may consolidate or aggregate Personal Information in a non-identifiable form (anonymized/Pseudonymized data) to help Gilead improve product design and services, to enhance Gilead’s research activities, and to facilitate other business functions.
DISCLOSURE OF INFORMATION TO OTHERS
We do not disclose any Personal Information about you to any third parties except as stated in this Privacy Statement or as notified to you, or as otherwise permitted by law, or authorized by you.
Third parties to whom we disclose information are required by law and contractual undertakings to keep your Personal Information confidential and secure; and to use and disclose it for purposes that a reasonable person would consider appropriate in the circumstances, in compliance with all applicable legislation, which purposes are as follows:
If these third parties wish to use your Personal Information for any other purpose, they will have a legal obligation to notify you of this and, where required, to obtain your consent. Contact us at email@example.com for more information on these third parties.
In the normal course of performing services for our clients, Personal Information may be shared within Gilead and its affiliates for research and statistical purposes, drug safety and efficacy purposes, disease management, system administration and crime prevention or detection, or any purpose otherwise identified in this Privacy Statement.
Because a number of the service providers we use in pursuance of the purposes mentioned above are located in countries other than your own, your Personal Information will be processed and stored inside those other countries, and those countries’ governments, courts, or law enforcement or regulatory agencies may be able to obtain disclosure of your Personal Information under local laws.
As we continue to develop our business, we might sell or buy assets. In such transactions, user information, including Personal Information, generally is one of the transferred business assets. Also, if either Gilead itself or substantially all of Gilead assets were acquired, your Personal Information may be one of the transferred assets. Therefore, we may disclose and/or transfer your Personal Information to a third-party in these circumstances.
Other Legally Required Disclosures
Gilead reserves the right to disclose without your prior permission any Personal Information about you or your use of this Site if Gilead has a good faith belief that such action is necessary to: (a) protect and defend the rights, property or safety of Gilead, employees, other users of this Site, or the public; (b) enforce the terms and conditions that apply to use of this Site; (c) as required by a legally valid request from a competent governmental authority and/or to comply with a judicial proceeding, court order, or legal process; or (d) respond to claims that any content violates the rights of third parties. We may also disclose Personal Information as we deem necessary to satisfy any applicable law, regulation, legal process, or governmental request.
Where Gilead relies on consent for the fair and lawful processing of Personal Information, the opportunity to consent will be provided prior to when the Personal Information in question is collected. Your consent may be given through your authorized representative such as a legal guardian, agent, or holder of a power of attorney. Where Gilead relies on consent, you will be entitled to withdraw that consent at any time.
For SPI, Gilead will provide individuals the opportunity to affirmatively and explicitly authorize or consent to the collection, processing, transfer, or disclosure of their SPI to a non-Agent third party or the use of their SPI for a purpose other than the one for which the individual originally consented.
Gilead will not disclose your Personal Information to third parties except as otherwise stated in this Privacy Statement or otherwise notified to you.
Gilead maintains servers and other storage facilities in the United States, EU, and Asia. Gilead may transfer Personal Information outside of its country of origin for the purposes, and in the manner, set out above; including for processing and storage by Service Providers and Affiliates in connection with such purposes. In all situations, Gilead takes reasonable steps to ensure that your privacy is protected. Such steps include, but are not limited to: implementing privacy, security, and contractual controls; as well as steps noted above, as required by applicable law. To the extent that any Personal Information is sent out of an individual’s country, it is subject to the laws of the country in which it is held, and may be subject to disclosure to the governments, courts, or law enforcement or regulatory agencies of such other country, pursuant to the laws of such country, consistent with the Principles.
Accountability for Onward Transfers: Gilead will obtain assurances from its Service Providers and Affiliates that they will safeguard Personal Information consistent with this Privacy Statement. An example of appropriate assurances that may be provided by Service Providers and Affiliates includes a contractual obligation that they provide at least the same level of protection as is required by Gilead’s privacy principles set out in this Privacy Statement. Where Gilead has knowledge that a Service Provider or Affiliate is using or disclosing Personal Information in a manner contrary to this Privacy Statement, Gilead will take appropriate steps to prevent or stop the use or disclosure. Gilead also complies with the Privacy Shield Principle regarding liability for onward transfers.
Gilead has implemented reasonable physical, technical and managerial controls and safeguards to keep your Personal Information protected from unauthorized access, disclosure, alteration, and destruction. Such measures may include, but are not limited to: the encryption of communications via SSL, encryption of information while it is in storage, firewalls, access controls, separation of duties, and similar security protocols.
Access to Personal Information is limited to a restricted number of Gilead employees whose duties reasonably require such information, Agents with whom Gilead contracts to carry out business activities for Gilead, and, with an individual’s consent, certain companies with which Gilead may conduct joint programs. Gilead trains its employees on the importance of privacy and how to handle and manage Personal Information appropriately and securely. Personal Information handled by Agents, or companies with which Gilead may conduct joint programs, is governed by this Privacy Statement and the Principles.
Data Integrity and Purpose Limitation
Gilead will use Personal Information only in ways that are compatible with the purposes for which it was collected, or consented to by the individual. Gilead will have appropriate steps in place to ensure that Personal Information is relevant to its intended use, accurate, complete, and current. Gilead will only store Personal Information for as long as it is needed to fulfill the purposes for which it was collected, subject to applicable data retention periods imposed upon Gilead by applicable law. This may mean that your Personal Information is stored by Gilead for a number of years, depending on the purpose and need for that data to be processed. For more information about Gilead’s retention periods for Personal Information, please refer to the contact information section below.
Where individuals have rights under laws applicable to them and upon written request, Gilead will grant individuals access to Personal Information that it holds about them, subject to any legal restrictions. In addition, Gilead will permit individuals to correct, amend, or delete information that is demonstrated to be inaccurate or incomplete or to object to certain types of processing of such information or to data portability, in certain circumstances and subject to certain exceptions provided by law. Gilead may not be able to comply with a request where Personal Information has been destroyed, erased or made anonymous in accordance with Gilead’s record retention obligations and practices. In the event that Gilead cannot provide an individual with access to his/her Personal Information, Gilead will endeavor to provide the individual with an explanation, subject to any legal or regulatory restrictions.
Recourse Enforcement and Liability
Individuals may contact Gilead regarding any question or complaint regarding the collection, processing, and transfer of their Personal Information by completing the Gilead Privacy Inquiry Form and by emailing it to firstname.lastname@example.org. Gilead will promptly investigate and respond to complaints within 45 calendar days of their receipt. Gilead will attempt to resolve complaints, disputes and requests to revoke consent regarding collection, processing, transfer, and disclosure of Personal Information in accordance with the principles contained in this Privacy Statement, and the Principles.
Gilead will conduct periodic compliance audits of its relevant privacy practices to verify adherence to this Privacy Statement. Independent Recourse Mechanism
If you have an unresolved privacy or data use concern that we have not addressed satisfactorily, please contact our U.S.-based third party dispute resolution provider (free of charge), TRUSTe, at https://feedback-form.truste.com/watchdog/request. Binding Arbitration
In the event that you cannot fully resolve your complaint through the above mechanisms, it is possible that you may use binding arbitration as a final resort. In order to invoke this arbitration option you must take the following steps prior to initiating an arbitration claim: (1) raise the claimed violation directly with Gilead and afford us an opportunity to respond to the issue within 45 days; (2) make use of the independent recourse mechanism, in this case TRUSTe, which is at no cost to you; and (3) raise the issue through your Data Protection Authority to the Department of Commerce and afford the Department of Commerce an opportunity to use best efforts to resolve the issue.
This arbitration option may not be invoked if your same claimed violation (1) has previously been subject to binding arbitration; (2) was the subject of a final judgment entered in a court action to which you were a party; or (3) was previously settled by you and us. In addition, you may not invoke this option where the Data Protection Authority of the country of your residence already has jurisdiction to resolve your complaint.
You may initiate binding arbitration, subject to the pre-arbitration requirements provision above, by delivering a “Notice” to the organization. The Notice shall contain a summary of steps taken to resolve the claim, a description of the alleged violation, and, at the choice of the individual, any supporting documents and materials and/or a discussion of law relating to the alleged claim. For more information on how to invoke arbitration under the Privacy Shield Framework, please visit https://www.privacyshield.gov/article?id=ANNEX-I-introduction.
Finally, you may only use binding arbitration to ensure Gilead follows the data handling practices set out in this Privacy Statement. No other form of remedy is available by any arbitration under this section.
Any questions or concerns regarding handling of Personal Information by Gilead, or related to revocation of consent to collect, process, transfer, or disclose your Personal Information should be directed by email to email@example.com.
Any requests to opt-out of future communications from Gilead, or to opt-out of a particular Gilead program should be directed to Gilead by e-mail at firstname.lastname@example.org, or by phone at by telephone at +1 (800) GILEAD5 or +1 (650) 522-5775.
Alternatively, letters may be sent to the following address:
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404
All communications to Gilead should include the individual’s name and contact information (such as e-mail address, phone number, or mailing address), and a detailed explanation of the request. E-mail requests to delete, amend, or correct Personal Information should include “Deletion Request” or “Amendment/Correction Request,” as applicable, in the subject line of the e-mail. Gilead will endeavor to respond to all reasonable requests in a timely manner, and in any case, within any time limits prescribed by applicable local law.
Changes To Gilead Privacy Statements
Gilead reserves the right to amend this Privacy Statement from time to time to reflect technological advancements, legal and regulatory changes, and Gilead’s business practices, subject to applicable laws. If Gilead changes its privacy practices, an updated version of this Privacy Statement will reflect those changes. Gilead will provide notice of such changes by updating the effective date listed on this Privacy Statement. It is your responsibility to check this Privacy Statement frequently to view any amendments. Your continued interaction with Gilead, in the activities covered above, will be subject to the then-current Privacy Statement.
If you are an EU citizen and/or accessing Gilead Websites in the European Economic Area, then this Supplement may apply in addition to the above.
Transfers of your Personal Information may be made to entities located outside the European Economic Area, including entities located in the United States, for processing consistent with the purposes above. Gilead will implement appropriate contractual measures (including our Privacy Shield certification and standard data protection clauses, a copy of which you can obtain by contacting email@example.com) to ensure that the relevant Gilead companies and third parties outside the European Economic Area provide an adequate level of protection to your Personal Information as set out in this notice and as required by applicable law. For the processing of Personal Information relating to the European Economic Area, Gilead has assigned a data protection officer responsible for overseeing our compliance with EU data protection law, who you may contact at firstname.lastname@example.org in case of any questions or concerns regarding the processing of your Personal Information.
If Gilead’s processing of your Personal Information is covered by EU law you may also lodge a complaint with the corresponding data protection supervisory authority in your country of residence. You can find the relevant supervisory authority name and contact details under http://ec.europa.eu/justice/data-protection/bodies/authorities/index_en.htm.
Last Updated: 15 May, 2018
Disclaimer of Warranties and Limitation of Liability
GILEAD MAINTAINS THIS GILEAD WEBSITE AS A SERVICE TO THE INTERNET COMMUNITY. THIS GILEAD WEBSITE IS DESIGNED TO PROVIDE GENERAL INFORMATION ABOUT THE SUBJECT MATTER PRESENTED.
Gilead will use reasonable efforts to include accurate and up-to-date information on this Gilead website, but all information is provided "AS IS." Gilead makes no warranties or representations as to the accuracy of information presented on this Gilead website and disclaims all warranties, express or implied, including any warranties of merchantability, fitness for a particular purpose, and non-infringement to the full extent permitted by applicable law.
In addition, any information presented on this Gilead website as of a particular date may only be accurate as of such date and Gilead disclaims any responsibility to update such information. Gilead shall not be held responsible for any action taken that is based on the information presented on this Gilead website, and all users of this Gilead website agree that all access and use of this Gilead website, and any and all content presented on this Gilead website, is at the user's own risk.
Neither Gilead nor any of its agents or affiliates shall be liable for any direct, incidental, consequential, indirect, or punitive damages arising out of user's access, use, or inability to use this Gilead website, or any errors or omissions in the content of this Gilead website.
Any communication or material you transmit to Gilead via this Gilead website or Internet electronic mail is transmitted by you on a non-confidential basis. Gilead makes no promise, express or implied, not to use such communication or material for any purpose whatsoever, including reproduction, publication, broadcast and posting.
This Gilead website does not, and is not intended to, provide medical advice, nor does it provide instruction on the appropriate use of any product produced or supplied by Gilead, its affiliates, related companies, or its licensors or joint venture partners. Information on this Gilead website regarding any product(s) approved for marketing is qualified in its entirety by reference to the FDA-approved full prescribing information for the specific product(s). Users of this Gilead website should be aware that any product(s) under development described herein have not been found safe or effective by any regulatory agency and are not approved for any use outside of clinical trials. The information presented on this Gilead website should not be interpreted or construed in any way as a replacement or substitution for medical advice provided by your doctor or healthcare provider. It is important that you discuss your treatment options and any questions that you may have with your doctor or healthcare provider.
News & Press Releases
This Gilead website may contain information, news, and/or press releases, the content of which is accurate or current only as of the date of the particular information, news, press release, or posting. Gilead does not update press releases once they have been made public.
Intellectual Property: Copyrights & Trademarks
The Gilead company name and logo, and all product names, regardless of whether or not they appear in large print or with a trademark symbol, are trademarks of Gilead, its affiliates, related companies, or its licensors or joint venture partners, unless otherwise noted. Use, reproduction, copying, or redistribution of these trademarks, without the written permission of Gilead is prohibited.
The entire content of this Gilead website, including any images or text, is protected by copyright. In consideration for your agreement to these terms and conditions, Gilead grants you a personal, non-exclusive, non-transferable license to access and use this Gilead website. You may download material from this Gilead website only for personal, non-commercial use, and this Gilead website may not be copied, distributed, downloaded, modified, reused, reposted, or otherwise exploited except as provided herein without the express written permission of Gilead. It is the policy of Gilead to enforce its intellectual property rights to the fullest extent permitted under law. The use or misuse of these trademarks, copyrights, or other materials, except as permitted herein, is expressly prohibited and may be in violation of copyright law, trademark law, communications regulations and statutes, and other laws, statutes, and/or regulations.
Third Party Websites
Gilead's Website may include hyperlinks to websites maintained or controlled by others. Gilead is not responsible for and does not routinely screen, approve, review or endorse the contents of or use of any of the products or services that may be offered at these websites.
Saving videos to your iPhone or iPad requires a free third-party application. Follow the steps below to continue:
1. Download and install Documents by Readdle from the App Store
2. Select a video quality level below. When prompted to 'Open this page in "Documents"?', select Open
3. In the Documents app, select Done to download and save the video to your device
4. The video is now saved to the Downloads folder of the Documents app
"I found the educational resources on the Gilead's HIV Academy website useful and thought you might be interested.
You can register for free to gain access to the site here: https://HIV-Academy.com/register"